• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Amneal`s Generic Azelastine Hydrochloride Receives Approval in US

    FDA

    Padagis` Generic Azelastine Hydrochloride Receives Approval in the U.S.

    FDA

    Aurobindo Pharma`s Generic Azelastine Hydrochloride Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of June 7, 2023

    FDA

    Glenmark bets on respiratory drug, licensing deals to improve business

    ECONOMIC TIMES

    Amneal`s Generic Azelastine HCL Receives Tentative Approval in the U.S.

    FDA

    Astepro Allergy, Steroid-Free Antihistamine Nasal Spray Now Available OTC

    BUSINESSWIRE

    BAYER AND MEDA SUE APOTEX OVER PROPOSED ASTEPRO ALLERGY GENERIC

    LAWYER-MONTHLY

    FDA Confirms Paragraph IV Patent Challenge of Children`s Astepro Allergy (OTC) 21382 (Azelastine Hydrochloride) 205.5mcg/20ml nasal spray

    FDA

    FDA Confirms Paragraph IV Patent Challenge of Astepro Allergy (OTC) 21382 (Azelastine Hydrochloride) 205.5mcg/20ml nasal spray

    FDA

    FDA Approves Bayer’s Nasal Antihistamine for Nonprescription Use

    FIERCEPHARMA

    Aurobindo Pharma Ltd`s Generic Azelastine Hydrochloride Receives Approval In US

    FDA

    CEBINA reports findings on the potency of azelastine as anti-COVID-19 approach

    BIOSPACE

    Aurobindo Pharma`s Generic Azelastine Hydrochloride Receives Approval in US

    FDA

    Gland Pharma`s Generic Azelastine Hydrochloride Receives Approval in US

    FDA

    Hi-Tech Generic Azelastine Hydrochloride Approval in US

    FDA

    Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.15%

    GLOBENEWSWIRE

    Akorn Inc. Receives FDA Warning Letter

    FDA

    Hi-Tech`s Generic Azelastine Hydrochloride Approval in US

    FDA

    Enforcement Report - Week of February 13, 2019

    FDA

    FDA Hands Akorn 483 Over GMP Issues at New Jersey Site

    RAPS

    Akorn Inc. Receives FDA Form 483

    FDA

    Enforcement Report - Week of August 15, 2018

    FDA

    FTC Approves Merger of Generic Drug Marketers Amneal, Impax

    FTC GOV

    FTC imposes conditions on Amneal acquisition of Impax

    PHARMA LETTER

    Enforcement Report - Week of February 21, 2018

    FDA

    Amneal Pharm’s Generic Azelastine Hydrochloride Receives Approval In US

    FDA

    West-Ward Pharm’s Generic Azelastine Hydrochloride Receives Approval In US

    FDA

    Alkem Lab’s Generic Azelastine Hydrochloride Receives Approval In US

    FDA

    Zydus Pharm’s Generic Azelastine Hydrochloride Receives Approval In US

    FDA

    Zydus Cadila gets USFDA nod for blood pressure drug

    ECONOMIC TIMES

    Mylan confirms plan to close Meda Soma plant in Illinois

    IN PHARMATECHNOLOGIST

    Upsher-Smith Labs Generic Azelastine Hydrochloride Receives Approval In US

    FDA

    West-Ward`s Generic Azelastine Receives Tentative Approval In US

    FDA

    FDA Written Request for Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.